142.35 USD
-1.69 (-1.17%)
142.35 USD
0 (0%)
Overall ICUI gets a fundamental rating of 4 out of 10. We evaluated ICUI against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of ICUI get a neutral evaluation. Nothing too spectacular is happening here. ICUI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year ICUI was profitable.
In the past year ICUI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ICUI reported negative net income in multiple years.
Of the past 5 years ICUI 4 years had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of -0.18%, ICUI is doing good in the industry, outperforming 72.34% of the companies in the same industry.
ICUI has a Return On Equity of -0.35%. This is in the better half of the industry: ICUI outperforms 72.87% of its industry peers.
The Return On Invested Capital of ICUI (2.86%) is better than 70.74% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ICUI is significantly below the industry average of 8.78%.
The last Return On Invested Capital (2.86%) for ICUI is above the 3 year average (1.36%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROIC | 2.86% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
ICUI's Operating Margin of 5.63% is fine compared to the rest of the industry. ICUI outperforms 70.74% of its industry peers.
ICUI's Operating Margin has declined in the last couple of years.
ICUI has a Gross Margin of 36.47%. This is in the lower half of the industry: ICUI underperforms 70.21% of its industry peers.
ICUI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICUI is destroying value.
Compared to 1 year ago, ICUI has more shares outstanding
The number of shares outstanding for ICUI has been increased compared to 5 years ago.
The debt/assets ratio for ICUI is higher compared to a year ago.
2.2 Solvency
ICUI has an Altman-Z score of 2.20. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.20, ICUI is in the better half of the industry, outperforming 62.77% of the companies in the same industry.
ICUI has a debt to FCF ratio of 21.21. This is a negative value and a sign of low solvency as ICUI would need 21.21 years to pay back of all of its debts.
ICUI's Debt to FCF ratio of 21.21 is fine compared to the rest of the industry. ICUI outperforms 69.15% of its industry peers.
A Debt/Equity ratio of 0.62 indicates that ICUI is somewhat dependend on debt financing.
ICUI has a worse Debt to Equity ratio (0.62) than 63.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Altman-Z | 2.2 |
ROIC/WACC0.38
WACC7.51%
2.3 Liquidity
ICUI has a Current Ratio of 2.45. This indicates that ICUI is financially healthy and has no problem in meeting its short term obligations.
ICUI's Current ratio of 2.45 is in line compared to the rest of the industry. ICUI outperforms 47.87% of its industry peers.
A Quick Ratio of 1.19 indicates that ICUI should not have too much problems paying its short term obligations.
The Quick ratio of ICUI (1.19) is worse than 68.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 40.14% over the past year.
The Earnings Per Share has been decreasing by -5.28% on average over the past years.
ICUI shows a decrease in Revenue. In the last year, the revenue decreased by -0.84%.
Measured over the past years, ICUI shows a quite strong growth in Revenue. The Revenue has been growing by 13.47% on average per year.
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
3.2 Future
The Earnings Per Share is expected to grow by 14.56% on average over the next years. This is quite good.
ICUI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.95% yearly.
EPS Next Y14.6%
EPS Next 2Y14.9%
EPS Next 3Y15.92%
EPS Next 5Y14.56%
Revenue Next Year-5.53%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y2.95%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ICUI is valuated rather expensively with a Price/Earnings ratio of 17.88.
Based on the Price/Earnings ratio, ICUI is valued cheaper than 84.04% of the companies in the same industry.
When comparing the Price/Earnings ratio of ICUI to the average of the S&P500 Index (26.41), we can say ICUI is valued slightly cheaper.
ICUI is valuated rather expensively with a Price/Forward Earnings ratio of 17.34.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICUI indicates a rather cheap valuation: ICUI is cheaper than 81.91% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.40, ICUI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.88 | ||
| Fwd PE | 17.34 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ICUI is valued cheaper than 84.04% of the companies in the same industry.
72.87% of the companies in the same industry are more expensive than ICUI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 56.47 | ||
| EV/EBITDA | 13.72 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ICUI's earnings are expected to grow with 15.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.22
PEG (5Y)N/A
EPS Next 2Y14.9%
EPS Next 3Y15.92%
5. Dividend
5.1 Amount
ICUI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
142.35
-1.69 (-1.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners113.8%
Inst Owner Change3.93%
Ins Owners0.98%
Ins Owner Change-1.93%
Market Cap3.51B
Revenue(TTM)2.32B
Net Income(TTM)-7.36M
Analysts83.33
Price Target185.03 (29.98%)
Short Float %5.5%
Short Ratio4.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.05%
Min EPS beat(2)37.25%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)36.86%
Min EPS beat(4)31.74%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)33.65%
EPS beat(12)12
Avg EPS beat(12)26.3%
EPS beat(16)15
Avg EPS beat(16)20.15%
Revenue beat(2)1
Avg Revenue beat(2)0.69%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)3.14%
Revenue beat(4)3
Avg Revenue beat(4)1.65%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.14%
Revenue beat(8)6
Avg Revenue beat(8)1.04%
Revenue beat(12)6
Avg Revenue beat(12)-0.86%
Revenue beat(16)8
Avg Revenue beat(16)-0.49%
PT rev (1m)2.02%
PT rev (3m)2.95%
EPS NQ rev (1m)-0.97%
EPS NQ rev (3m)-0.97%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.88 | ||
| Fwd PE | 17.34 | ||
| P/S | 1.51 | ||
| P/FCF | 56.47 | ||
| P/OCF | 22.04 | ||
| P/B | 1.65 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.72 |
EPS(TTM)7.96
EY5.59%
EPS(NY)8.21
Fwd EY5.77%
FCF(TTM)2.52
FCFY1.77%
OCF(TTM)6.46
OCFY4.54%
SpS93.98
BVpS86.16
TBVpS-1.47
PEG (NY)1.22
PEG (5Y)N/A
Graham Number124.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROCE | 3.62% | ||
| ROIC | 2.86% | ||
| ROICexc | 3.12% | ||
| ROICexgc | 9.01% | ||
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% | ||
| FCFM | 2.68% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Debt/EBITDA | 3.95 | ||
| Cap/Depr | 47.91% | ||
| Cap/Sales | 4.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 47.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.2 |
F-Score7
WACC7.51%
ROIC/WACC0.38
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
EPS Next Y14.6%
EPS Next 2Y14.9%
EPS Next 3Y15.92%
EPS Next 5Y14.56%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
Revenue Next Year-5.53%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y2.95%
EBIT growth 1Y142.55%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year37.73%
EBIT Next 3Y15.54%
EBIT Next 5Y17.88%
FCF growth 1Y597.89%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y117.81%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%
ICU MEDICAL INC / ICUI FAQ
What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ICUI.
What is the valuation status of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a valuation rating of 6 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.
How profitable is ICU MEDICAL INC (ICUI) stock?
ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.
What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?
The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 14.6% in the next year.